Skip to main content
Clinical Trials/ISRCTN96308751
ISRCTN96308751
Completed
未知

Intramedullary Nail versus Sliding hip screw Inter-Trochanteric Evaluation (INSITE): a multicenter randomized controlled trial

Stryker Trauma GmbH (Germany)0 sites736 target enrollmentOctober 18, 2011

Overview

Phase
未知
Intervention
Not specified
Conditions
Trochanteric fracture
Sponsor
Stryker Trauma GmbH (Germany)
Enrollment
736
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 18, 2011
End Date
March 1, 2017
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Stryker Trauma GmbH (Germany)

Eligibility Criteria

Inclusion Criteria

  • Current inclusion criteria as of 05/04/2012:
  • 1\. Adult men or women aged 18 years and older (with no upper age limit)
  • 2\. An intertrochanteric fracture (stable or unstable), AO Type 31\-A1 or 31\-A2, confirmed with anteroposterior and lateral hip radiographs, computed tomography, or magnetic resonance imaging (MRI)
  • 3\. Low energy fracture (defined as a fall from standing height)
  • 4\. No other major trauma
  • 5\. Patient was ambulatory prior to fracture, though they may have used an aid such as a cane or a walker
  • 6\. Anticipated medical optimization of the patient for operative fixation of the proximal femur
  • 7\. Operative treatment within 7 days after the trauma (operative treatment should take place as soon as possible as permitted by each institution's standard of care)
  • 8\. Provision of informed consent by patient or proxy
  • Previous inclusion criteria:

Exclusion Criteria

  • Current exclusion criteria as of 05/04/2012:
  • 1\. Associated major injuries of the lower extremity (i.e. ipsilateral and/or contralateral fractures of the foot, ankle, tibia, fibula, or knee; dislocations of the ankle, knee, or hip)
  • 2\. Retained hardware around the affected proximal femur
  • 3\. Infection around the proximal femur (i.e. soft tissue or bone)
  • 4\. Patients with disorders of bone metabolism other than osteoporosis (i.e. Paget's disease, renal osteodystrophy, or osteomalacia)
  • 5\. Patients with Parkinson's disease severe enough to increase the likelihood of falling or severe enough to compromise rehabilitation
  • 6\. Patients with a subtrochanteric fracture
  • 7\. Patients with a pathologic fracture
  • 8\. Patients with a reverse oblique fracture pattern, fracture AO Type 31\-A3
  • 9\. Obesity in the judgment of the attending surgeon

Outcomes

Primary Outcomes

Not specified

Similar Trials